Phase III trial of Rapamune versus placebo in primary renal allograft recipients

Author： Ponticelli C. MacDonald A.S. Rajagopalan P. Sindhi R. Mathew T. for the Rapamicin Global Study Group

Publisher： Elsevier

ISSN： 0041-1345

Source： Transplantation Proceedings, Vol.33, Iss.3, 2001-05, pp. : 2271-2272

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Randomised trial of simulect versus placebo for control of acute rejection in renal allograft recipients

By Bingyi S. Yeyong Q. Ming C. Chunbai M. Wenqiang Z.

Transplantation Proceedings, Vol. 35, Iss. 1, 2003-02 ,pp. : 192-194

Elsevier

Access to resources Recommend Favorite

Trial of steroid withdrawal in renal transplant recipients with long-term-surviving allograft

By Mizuno Y. Kikuchi H. Fujimori K. Doi H. Orii T. Ohkohchi N. Satomi S.

Transplantation Proceedings, Vol. 32, Iss. 7, 2000-11 ,pp. : 1677-1678

Elsevier

Access to resources Recommend Favorite

Primary tacrolimus-based immunosuppression in renal allograft recipients: - A single center experience

By Lye W.C.

Transplantation Proceedings, Vol. 32, Iss. 7, 2000-11 ,pp. : 1700-1701

Elsevier

Access to resources Recommend Favorite

Survival on Hemodialysis Versus Renal Transplantation Following Primary Renal Allograft Failure

By Denny R.R. Sumrani N. Miles A.M.V. Dibenedetto A. Distant D.A. Hong J.H. Markell M. Friedman E.A. Sommer B.G.

Transplantation Proceedings, Vol. 29, Iss. 8, 1997-12 ,pp. : 3602-3604

Elsevier

Access to resources Recommend Favorite

Soluble FAS in renal allograft recipients

By Nishioka T. Minami T. Matsumoto S. Nose K. Wakasugi E. Kunikata S. Akiyama T. Kurita T.

Transplantation Proceedings, Vol. 32, Iss. 7, 2000-11 ,pp. : 1784-1784

Elsevier

Access to resources Recommend Favorite